Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.75 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |
| Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €2.86 | €10.55 | 268.734% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.50 | €144.44 | 12.408% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.40 | €50.00 | 26.904% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.90 | €5.51 | 515.469% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Centene Corp. | 15 | 0 | 3 | 0 | €72.22 | €82.57 | 14.332% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €93.00 | €124.85 | 34.245% |
| Stryker Corp. | 23 | 0 | 7 | 0 | €306.90 | €335.03 | 9.165% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.56 | €80.00 | 13.379% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.53 | €4.63 | 30.968% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €75.50 | €75.94 | 0.577% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €72.50 | €79.00 | 8.966% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.20 | €248.57 | 17.139% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €189.20 | - | - |
| Lightpath Techs A | 4 | 0 | 1 | 0 | €1.29 | €2.78 | 115.860% |
| Cutera Inc. | 2 | 0 | 1 | 0 | €2.02 | €3.75 | 85.736% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.85 | €26.01 | 31.048% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €26.40 | €28.29 | 7.162% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €69.00 | €69.00 | 0.000% |